跳至主要内容
临床试验/NCT00684697
NCT00684697已完成不适用

Double Blind Randomized Placebo Controlled Trial of Iron Supplementation in Premature Infants

University of Rochester1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
mean interpeak latency Auditory Neural Myelination

研究概览

简要总结

Premature infants with iron deficiency if supplemented with more elemental iron than the routine 2mg/kg/day will have improved brain development.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 32 Weeks(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Babies less than or equal to 33 weeks gestational age

排除标准

  • •Infants with cranio-facial malformations
  • •Torch infections
  • •Infants with hearing disorders
  • •Infants receiving erythropoietin
  • •Infants with subnormal vitamin E levels
  • •Infants with severe anemia
  • •Infants who are not on full feeds
  • •Infant with in-utero exposure to cocaine

研究组 & 干预措施

3

Experimental

High Iron dose

干预措施: iron (Dietary Supplement)

2

Active Comparator

intermediate iron dose

干预措施: iron (Dietary Supplement)

1

Placebo Comparator

low iron dose

干预措施: iron (Dietary Supplement)

结局指标

主要结局

mean interpeak latency Auditory Neural Myelination

时间窗: 43-45 weeks PMA

This will be measured using auditory brain stem response.

mean visual neural myelination

时间窗: 43-45 weeks PMA

Visual myelination will be evaluated by visual evoked response.

次要结局

  • number of participants with executed function(3-5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验